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Abstract  
Background: Word finding difficulty is one of the most common features of aphasia.  
Semantic Features Analysis (SFA) directly aims to improve word finding in people with 
aphasia.  Evidence from systematic reviews suggests that SFA leads to positive 
outcomes, yet the evidence comprises single case studies and case series. There is a need 
to evaluate the efficacy of SFA in controlled group studies/trials. 
Aims: To evaluate the efficacy of Elaborated Semantic Feature Analysis (ESFA) for 
word finding in people with aphasia. We investigated: (a) the efficacy of ESFA versus a 
delayed therapy/control, (b) the efficacy of two therapy approaches– individual versus a 
combination of individual and group therapy.  
Methods and procedures: We ran a multi-centre, quasi-randomised controlled trial, 
nested in a larger study (Thales-Aphasia). Participants were recruited from community 
settings.  They had to be people with aphasia due to stroke at least four months post-
onset.  Participants were randomized to individual vs combination vs delayed 
therapy/control groups. Both therapy groups had three hours of ESFA per week for 12 
weeks.  Delayed therapy/control group had no intervention for 12 weeks and were then 
randomized to either individual or combination therapy.  The primary outcome was 
confrontation naming. Secondary outcomes were the Boston Naming Test, Discourse, the 
Functional Assessment of Communication Skills for adults (ASHA–FACS), the Stroke 
and Aphasia Quality of Life scale (SAQOL-39g), the General Health Questionnaire-12 
item, and the EQ-5D.  
Outcomes and Results: Of the 72 participants of the Thales-Aphasia project, 58 met 
eligibility criteria for speech-language therapy and 39 were allocated to ESFA. The 
critical p-value was adjusted for multiple comparisons (.005). For the therapy versus 
control comparison, there was a significant main effect of time on the primary outcome 
(p<.001, η2p=.42) and a significant interaction effect (p=.003, η2p=.21).  An interaction 
effect for the SAQOL-39g (p=.015, η2p=.11) and its psychosocial domain (p=.013, 
η2p=.12) did not remain significant after Bonferroni adjustment. For the individual versus 
combination ESFA comparison, there were significant main effects of time on the 
primary outcome (p<.001, η2p=.49), the BNT (p<.001, η2p=.29) and the ASHA-FACS 
(p=.001, η2p=.18). Interaction and group effects were not significant.  
Conclusion: Though underpowered, this study provides evidence on the efficacy of 
ESFA to improve word finding in aphasia, with gains similar in the two therapy 
approaches.  
 
Trial registration: ISRCTN71455409, https://doi.org/10.1186/ISRCTN71455409  
 
Keywords  
Aphasia; Therapy; Elaborated Semantic Features Analysis; Efficacy; Randomised 
Controlled Trial. 
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Introduction  
The most common cause of aphasia is a stroke.  It is estimated that 45% of people 
with stroke have aphasia, with 24% having persistent problems (Ali, Lyden & Brady, 
2015).  Stroke survivors with aphasia are less likely to survive than those without (Laska, 
Hellblom, Murray, Kahan & Von Arbin, 2001); and tend to have worse rehabilitation 
outcomes (Astrom, Adolfsson & Asplund, 1993). Aphasia has a profound impact on 
people’s lives, with consequences including social isolation and poor quality of life for 
themselves and their family members (Grawburg, Howe, Worrall & Scarinci, 2013; 
Hilari, Needle & Harrison, 2012; Winkler, Bedford, Northcott & Hilari, 2014; Northcott, 
Moss, Harrison & Hilari, 2016). 
Aphasia severity and communication disability are predictors of health related 
quality of life in people with aphasia post stroke (Hilari et al., 2012).  Reducing the 
impairment caused by aphasia may alleviate some of its negative consequences. One of 
the most common features of aphasia is difficulty finding the words one wants to say. 
Naming therapies directly aim to address word finding difficulties and have been 
extensively tested in the aphasia literature using case studies and case series.  A recent 
Cochrane review identified only seven trials (275 participants) evaluating naming 
outcomes in aphasia and graded the quality of the evidence as low (Brady, Godwin, 
Enderby, Kelly & Campbell, 2016). 
A therapy that directly aims to improve naming and word finding in people with 
aphasia is Semantic Features Analysis (SFA, Boyle, 2010).  SFA aims to improve 
retrieval of words by stimulating semantic networks. During SFA treatment, the person 
with aphasia is guided to produce words semantically related to the target. For example, 
for ‘dog’, questions like ‘what is it?’, ‘what does it do?’ are asked to generate its semantic 
features, such as ‘it’s an animal’, ‘it’s a pet’, ‘it barks’, ‘it wags its tail’. According to the 
spreading activation theory of semantic processing (Collins & Loftus, 1975), activating 
the semantic network surrounding the target should activate the target itself, thus 
facilitating retrieval of the word. Evidence from two systematic reviews and meta-
analyses suggests that SFA leads to positive outcomes on naming despite variability in 
treatment procedures, dosage, and duration; with limited generalization to untrained items 
and connected speech (Efstratiadou, Papathanasiou, Holland, Archonti & Hilari, 2018; 
Oh, Eom, Park & Sung, 2016). None of the included studies in these meta-analyses were 
controlled trials. 
This study aimed to investigate the efficacy of SFA in a controlled trial/group 
design.  To the best of our knowledge, it is the first study to do this. To encourage 
generalization to connected speech, the elaborated version of SFA (ESFA) was used 
(Papathanasiou & Mihou, 2006), whereby, once the word is retrieved, the person with 
aphasia is asked to use it together with its semantic features in a phrase or sentence, e.g., 
‘the dog is wagging its tail’.  A second aim of the study was to explore if different 
approaches to delivering the therapy led to different outcomes: individual therapy vs. a 
combination of individual and group therapy. Based on the literature and given that group 
therapy involves increased interaction with other people with aphasia, we hypothesized 
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that it may lead to greater gains in functional communication (Elman, 2007); and 
potentially well-being and quality of life (Ownsworth, Fleming, Shum, Kuipers & Strong, 
2008). The specific objectives of the study were to:  
 
1) Evaluate the efficacy of ESFA therapy for people with aphasia, as compared to a 
delayed treatment control group.   
2) Evaluate the relative efficacy of ESFA therapy, as delivered in two different 
approaches - individual and combination (individual and group) therapy. 
 
Methods  
The Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement 
(www.consort-statement.org ) was followed in reporting this study and the CONSORT 
Checklist is provided as supplementary material. The study is registered with the WHO 
International Standards Randomised Controlled Trials Number (ISRCTN) Registry, 
identification number ISRCTN71455409 https://doi.org/10.1186/ISRCTN71455409 . 
 
Context: This study was nested within the Speech and Language Therapy stream 
of the Thales-Aphasia project “Levels of impairment in Greek Aphasia: relationship with 
processing deficits, brain region and therapeutic implications”, http://thales-
aphasia.phil.uoa.gr/, the largest investigation of aphasia and people with aphasia in 
Greece. The Speech and Language Therapy stream aimed to investigate the efficacy of 
word level (ESFA) and sentence level therapy (mapping therapy) for aphasia. In this 
paper we report on the efficacy of word level therapy (ESFA)  
Ethics: Ethical approval was obtained in both Greece and the United Kingdom. In 
Greece, the project was evaluated by two research ethics committees: The University 
Hospital of Patras (42/19.02.2013), for participants recruited in Achaia, and the 
University of Athens Eginitio Hospital (325/16-01-13) for participants recruited in Attica. 
In the UK, the project was approved by the Division of Language and Communication 
Science’s Proportionate Review Committee of the School of Health Sciences, City, 
University of London (PhD/12-13/17). 
Design:  This study is a quasi-randomized, single blinded controlled trial with a 
delayed treatment control group.  Participants were randomized based on the order of 
their enrolment in the study.  It is quasi-randomized for three reasons: i) participants were 
randomized after enrolment to the overall Thales-Aphasia project and before eligibility 
for speech and language therapy was checked. This resulted in participants being 
excluded for not meeting eligibility criteria after randomization and therefore uneven 
numbers in the groups. ii) participants were randomized to one of three groups: direct 
therapy, combination therapy, control/delayed therapy. Therapies offered were either 
Elaborated Semantic Features Analysis (ESFA) or mapping therapy. This study reports 
on those who were allocated to ESFA therapy. The decision on whether a person with 
aphasia would receive ESFA or mapping therapy was based on whether they had 
primarily word finding difficulties (ESFA) or sentence level difficulties (mapping). We 
determined this based on the aphasia severity rating scale of the Boston Diagnostic 
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Aphasia Examination (BDAE Greek version, Papathanasiou, Papadimitriou, Gavrilou & 
Mihou, 2008) and their naming on the Boston Naming Test (BNT Greek version, Simos, 
Kasselimis & Mouzaki, 2011). If they scored lower than 5/7 on 80% of the BDAE 
aphasia severity rating scale items (excluding auditory comprehension) and lower than 
20/45 on the BNT, they were allocated to ESFA. iii) The randomization process was 
modified during the trial (see ‘Changes to methods after trial start below). 
Participants and setting: Participants were identified, approached and recruited 
through six state hospitals and three private rehabilitation centres in Attica and Achaia 
participating in the Thales-Aphasia project. Participants were people with aphasia after 
stroke, meeting the following inclusion criteria: had a stroke, as reported by their 
referring clinician; were at least four months post stroke and medically stable; were 
Greek native speakers; were older than 18 years old; and had no considerable cognitive 
decline [scored ≥ 32 out of 38 on Brief Cognitive Screening Test (Routsis & Economou, 
2015), a test specifically developed for people with aphasia]. Participants were excluded 
if they did not live at home prior to stroke; had a known history of mental health 
problems and/or cognitive decline prior to stroke; had a history of other neurological or 
psychiatric problems; and if they received other speech language therapy during this 
research.   
Link clinicians from the recruiting sites referred potential participants to four 
neuropsychologists of the Thales-Aphasia project.  The Thales-Aphasia 
neuropsychologists visited potential participants, provided information on the project 
using aphasia friendly information sheets, and answered any questions participants may 
have had. They asked those interested to take part for permission to access their medical 
records in order to obtain information about stroke and relevant medical history and 
check eligibility for the study.  Those eligible were visited again, screened for cognition 
and written consent was obtained.   
Sample size: For a mixed (within and between subjects) ANOVA to achieve a 
medium effect size (f = 0.25), at an alpha level of p = 0.05, a total sample of 78 
participants gave 80% power; and a sample size of 92 gave 85% power.  We aimed to 
recruit 96 participants to allow for attrition, which is common in stroke studies.   
Randomization: Participants were randomized by the order of their enrollment in 
the study. To achieve n = 96, we planned to run two cycles of randomization of 16 
participants in each of the three groups.  The first 16 participants would be randomized to 
individual therapy, the second 16 to combination therapy, the third 16 to control group 
(16x3 = 48), and then the cycle would be repeated (48x2 = 96).  The neuropsychologists 
entered participants as they were enrolled into the study in a shared excel file, where 
randomization allocation was pre-marked by the trial manager. The trial manager was 
one of the Thales-Aphasia project treating speech and language therapists, who had no 
contact with participants until after randomization and baseline assessments were 
completed.  In terms of intervention assignment, as indicated above, whether participants 
had individual or combination therapy was determined by their enrollment order; whether 
they had ESFA or mapping therapy was determined by the Thales-Aphasia project 
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assessing speech and language therapists (Assessors) based on their baseline language 
scores as detailed above. 
Blinding: The study was single-blinded. The Assessors who carried out all 
assessments and outcome measurements were blinded to participant group allocation.  To 
ensure they remained blinded, they did not share an office with other researchers in the 
Thales-Aphasia project and they had no access to electronic datasets until data collection 
was finished. As this was a behavioural intervention, neither participants nor therapists 
delivering the intervention were blinded. 
Changes to methods after trial start: Originally, the study aimed to evaluate 
group therapy as well, but this was abandoned early in the study, as participants would 
only agree to have group therapy if they also had individual therapy with a speech and 
language therapist (i.e. combination therapy).  This amendment received ethics approval.  
The randomization cycles were also modified. First, due to a clerical error 18 participants 
were randomized to each of the three groups (direct, combination, delayed treatment 
control) in the first randomization cycle (n = 54).  Second, within the first randomization 
cycle, participant recruitment became increasingly slower and it became apparent that the 
planned sample size would not be reached within the timeframe of the project. As this 
study employed a delayed treatment control group, to ensure that as many participants as 
possible completed treatment and follow-up assessment before the project ended, no 
more participants were allocated to the control group after the first randomization cycle. 
Additionally, to ensure a more even allocation between direct and combination therapy, 
we decided to run more randomization cycles with a smaller number randomized in each 
group in each cycle.  Three more randomization cycles ran with 10 participants allocated 
to either direct or combination therapy in the second cycle, and four participants in the 
third and fourth cycle.  As a result, 27 participants were randomized to direct speech and 
language therapy (18+5+2+2), 27 to combination therapy (18+5+2+2) and 18 to 
control/delayed therapy (total n = 72).  Not all of these participants completed the study 
(see results). 
Procedure: After consent, the Thales-Aphasia neuropsychologists referred 
participants to the Thales-Aphasia Assessors. These were two speech and language 
therapists who were blinded to group allocation.  Thales-Aphasia Assessors performed all 
assessments. Two baseline assessments were carried out: one at study entry (week 1) and 
one six weeks later (week 6). Each assessment was completed in two sessions (each 
ranged from 90 to 120 minutes). Those who were allocated to a treatment condition 
commenced therapy at that point. They received therapy by a Thales-Aphasia treating 
speech and language therapist for 12 weeks. Those allocated to the control group had 12 
weeks of no contact with the Speech and Language Therapy research team. Participants 
were assessed again at that stage (week 19, post-therapy for those in treatment groups). 
Delayed therapy control group participants were then randomly allocated to individual or 
combination therapy and received therapy for 12 weeks. All participants were assessed 
again at that stage (week 32, follow-up for those in treatment groups, post-therapy for 
those in control). Delayed therapy group participants were assessed again 12 weeks later 
(week 45, follow-up).  Figure 1 illustrates participant flow in the study. 
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Intervention: The intervention tested was ESFA, which has been previously 
described in detail, including a Template for Intervention Description and Replication 
(TIDieR) checklist (Hoffmann et al., 2014), and has good evidence of treatment fidelity 
(Kladouchou, Papathanasiou, Efstratiadou, Christaki & Hilari, 2017).  In summary, 
participants received either 36 h of individual therapy (three 1-h sessions per week for 12 
weeks) or 36 h of a combination of individual and group therapy (two 45-min individual 
therapy sessions and one 1.5 h group session per week for 12 weeks). The sessions took 
place mainly in the participants’ home and some in hospital settings.  In therapy, the 
participant chose a picture from a stimulus set and the therapist asked them to name it. 
Then, presenting a semantic feature chart (as in Boyle, 2004), the therapist prompted the 
participant to think of and say words related semantically with the target word (semantic 
features). The chart included six categories: superordinate category, use, action, physical 
properties, location and association. To elicit features, the therapist asked questions or 
provided the participant with sentence completion cues. As part of the elaborated element 
of SFA used in this study, the therapist also asked the participant to write down the 
features generated. If needed, the therapist used an alphabet board to help participants 
write; and if they were unable to write, the therapist filled in the chart.  Then the 
participant was prompted to produce phrases with the target word and each of its features. 
In group therapy sessions, the same procedure was followed with participants asked in 
turn to complete the chart and produce phrases.  In time, the therapist gave participants 
the opportunity to interact and provide appropriate cues to each other. The therapist 
controlled turn taking to ensure individuals got similar amounts of exposure to targets 
and cues, whilst being mindful of disturbing peer-to-peer interactions as little as 
necessary. 
To select treatment stimuli, each participant completed an oral confrontation-
naming task of the 260 Snodgrass and Vanderwart pictures –colour version (Rossion & 
Pourtois, 2004) three times before starting therapy. The pictures were presented in a 
random order to each participant, without any cuing or feedback. It took approximately 
60 minutes to administer the full set of pictures, using a computerized task, and 
participants were given a maximum of 13 seconds to respond to each picture. The 
pictures that a participant failed to name on at least two trials were selected as potential 
treatment stimuli. Not all selected treatment items were used during therapy. Each 
participant was trained in a subset that was dependent on participant’s success on the 
probes that were taken during the therapy. 
Measures: The Greek version of the BDAE was used as a profiling measure to 
provide information on participants’ aphasia type and severity. The primary outcome 
measure was the oral confrontation-naming task of the 260 Snodgrass and Vanderwart 
pictures – colour version.  Secondary outcome measures comprised the Greek BNT; the 
American Speech and Hearing Association Functional Assessment of Communication 
Skills for Adults (ASHA FACS) (Frattali, Thompson, Holland, Wohl & 
Ferketic,1995a,1995b), which was completed by the partner / main carer of the 
participant with aphasia; discourse scores from the Cookie Theft Picture Description of 
the BDAE (BDAE; Goodglass & Kaplan, 1983): correct information units per min 
(CIU/min, Nicholas & Brookshire, 1993); Greek version of the General Health 
Questionnaire-12, (GHQ-12, Garyfallos et al., 1991); Greek version of the Stroke and 
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Aphasia Quality of Life Scale-39g scale (SAQOL-39g, Kartsona & Hilari, 2007; 
Efstratiadou et al., 2012) overall score and three subdomains; Greek version of EQ-5D 
(Kontodimopoulos et al., 2008). 
Data analysis: Descriptive statistics were used to summarize participant 
characteristics and scores on measures used. As 10 outcome measures were used in 
this study, a Bonferroni correction was applied (0.5/10 = 0.005) to the critical 
probability value.  To explore whether there was a significant difference between 
ESFA therapy versus no therapy (control group), mixed ANOVAs were carried out 
with two levels in the between factor (therapy vs. no therapy) and three levels in the 
within factor (week 1/baseline 1 (BL1), week 6/baseline 2 (BL2) and week 19, 
which was after 12 weeks of therapy for the therapy group (Post) and after 12 
weeks of no therapy / baseline 3 (BL3) for the control group). To explore the 
efficacy of individual ESFA vs. combination ESFA therapy approach, mixed 
ANOVAs were carried out with two levels in the between factor (type of therapy: 
individual vs. combination) and four levels in the within factor (four assessment 
time-points: two baselines, post therapy, and follow-up).  For the control group the 
assessment points of week 6 and week 19 were taken as the two baselines.  To 
ensure unbiased comparison among the randomized groups, intention to treat (ITT) 
analysis was used (Sainani, 2010). ITT avoids overoptimistic estimations of the 
efficacy of a therapy, which results after removing non-compliers (Gupta, 2011). 
ITT analysis includes all randomised patients in the groups to which they were 
randomly assigned, regardless of: a) their adherence with the entry criteria, b) the 
treatment they received, and c) subsequent withdrawal from the treatment or 
deviation from the protocol (Fisher et al., 1990).   The Last Observation Carried 
Forward (LOCF) method of ITT was used in this study (Gadbury, Coffey & 
Allison, 2003; Molnar, Hutton & Fergusson, 2008). This technique replaces a 
participant's missing values after dropout with the last available measurement and 
assumes that the participant's response would have been stable from the point of the 
dropout to trial completion, rather than worsening or improving.  
 
[figure 1 about here] 
 
Results 
The Thales-Aphasia project recruited a total of 72 participants between 25/02/2013 – 
16/03/2015, who were randomized to three groups: individual, combination, 
control/delayed therapy. Three-month follow up assessments were completed on 
30/11/2015.  Of the 72 participants, 14 participants were excluded as they: a) did not 
meet inclusion criteria (n=12), b) declined to participate to therapy (n=1) and c) lived in 
another city faraway from Athens (n=1). This resulted in uneven numbers of participants 
in the three groups: direct approach (n=23), combination approach (n=17) and control 
group – delayed therapy approach (n=18). Figure 1 shows participant flow in the study. 
Participants from the delayed therapy approach were randomized to direct or combination 
approach for treatment after the third evaluation (eight to direct and 10 to combination).  
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Thirty-nine participants were allocated to ESFA (18 from the individual therapy 
group, nine from the combination group, 12 from the delayed therapy group).  At the end 
of the study 22 individuals had received ESFA with direct, 14 with combination 
approach, and three had dropped out. No harms or unintended effects were reported.  One 
of the participants who dropped out did not complete the initial assessment process and 
therefore had no data to contribute to the analysis (ESFA n=38). For the other two 
participants who started the project and subsequently dropped out, we analysed their data 
as per ITT, in the therapy versus control / delayed therapy comparison. In the individual 
versus combination therapy comparison they could not be included in the analysis as they 
had no data to contribute: both these participants were control group participants who did 
not start therapy (one dropped out and the other was excluded as he started speech 
language therapy privately). As a result, findings are presented for: 
I) Efficacy of ESFA (individual and combination, n=26) vs. control/delayed treatment 
(n=12). 
II) Efficacy of individual (n=22) vs. combination (n=14) ESFA.  
 
 
Participant characteristics are presented in table 1 for those in the therapy and those in the 
control group.  The two groups were well matched in terms of their demographic and 
stroke related characteristics. The therapy group comprised 20 men and 6 women and the 
control/delayed therapy group 6 men and 6 women.  There were no significant 
differences between the groups in gender, age, marital status, years of education, time 
post onset, aphasia type, and aphasia severity. In both groups, the majority of participants 
was non-fluent (21/26 in therapy group; 7/12 in control group) and had severe or 
moderate aphasia (21/26 in therapy group; 9/12 in control group).  A surprising finding 
was the working status of the participants in our study, with ≥ 50% still working. This 
high proportion of people with aphasia at work is likely due to Greek legislation.  A 
substantial proportion (16/36) of our sample worked in the public sector and according to 
Greek legislation persons with aphasia have the right to continue on full pay for as many 
months’ post stroke as years they have worked. They are then assessed to determine their 
disability percentage. When the percentage is higher than 67% the person with aphasia 
can leave work on benefits. When the percentage is less than 67%, their employer has to 
place them in an appropriate work position in the public sector according to their abilities 
and qualifications.  This may explain the large proportion of people who worked in our 
sample, despite the severity of their aphasia. 
 
[table 1 about here] 
I) Efficacy of ESFA vs. control 
Changes in scores across time are presented in table 2 and figure 2 together with 
mixed ANOVA results. On the primary outcome measure, scores for the control group 
were similar (within 15 points) across the three assessment points.  Scores for the therapy 
group were similar between the two baselines but increased by > 40 points from the 
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highest baseline to the post therapy evaluation.  On the two-way mixed ANOVA, the 
effect of group was not significant. There was a significant main effect of time, 
Greenhouse-Geisser F (1.09, 39.38) = 26.04, p < .001 with a large effect size (η2p = .42).  
Pairwise comparisons showed there was a small (mean difference = 6.15) but significant 
difference between BL1 and BL2 (p = .002) and large (mean differences = 31.12 and 
24.96) significant differences between both BL1/BL2 and post-therapy/BL3 (ps < .001). 
Importantly, there was a significant interaction effect Greenhouse-Geisser F (1.09, 39.38) 
= 9.56, p = .003 with a large effect size (η2p = .21), whereby the therapy group improved 
significantly more from BL2 [mean (SD) = 61.96 (49.50)] to post-therapy [mean (SD) = 
104.38 (73.91)] than the control group [74.33 (62.94) and 81.83 (69.90), respectively]. 
On the secondary outcome measures, there was a significant main effect of time 
on the BNT, Greenhouse - Geisser F (1.45, 52.14) = 8.37, p = .002 with a large effect size 
(η2p = .19). Pairwise comparisons showed there were significant differences between the 
two baselines and post-therapy/BL3 (p = .004, p = .036). Though the increase in scores 
for the therapy group from BL2 to post-therapy was sharper, the interaction effect was 
not significant. There was an interaction effect on psychosocial (p = .013, η2p = .12) and 
overall quality of life (SAQOL-39g) (p = .015, η2p = .11), with only the therapy group 
improving from BL2 to post-therapy, but these were not significant after adjusting for 
multiple comparisons. 
[table 2 about here] 
[figure 2 about here] 
II) Efficacy of individual vs. combination ESFA 
In terms of participant characteristics, as above, the groups were well matched on 
their demographic and stroke related variables. Participants’ scores across time and 
mixed ANOVA results are presented in table 3 and figure 3. On the primary outcome 
measure the group effect was not significant. There was a significant main effect of time, 
Greenhouse-Geisser F (1.90, 64.53) = 32.95, p < .001 with large effect size (η2p = .49). 
Pairwise comparisons showed there was a small but significant difference between BL1 
and BL2 (mean difference = 10.23, p = .003), and large significant differences between 
the two baselines and post-therapy and between the two baselines and follow-up (mean 
difference range = 33.22 – 49.69, all ps < .001); the difference between post-therapy and 
follow-up was not significant. Though the combination group showed a slightly sharper 
increase from pre to post therapy, the interaction effect was not significant. 
On the secondary outcome measures there were no significant group effects. On 
the BNT, ASHA-FACS, and SAQOL-39 psychosocial and overall score there was a trend 
for the combination group mean scores to increase more sharply from BL2 to post-
therapy and then drop more from post-therapy to follow-up; yet there were no significant 
interaction effects.  The main effect of time was significant for the BNT (p < .001, η2p= 
.29), with significant differences between the two baselines and post therapy (ps < .001) 
and baseline 1 and follow up (p = .003); and for the ASHA-FACS (p = .001, η2p = .18), 
with a significant difference between baseline 1 and follow up (p = .005).  There was a 
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time effect for overall quality of life (p = .046, η2p = .09), which did not remain 
significant after adjusting for multiple comparisons. 
[table 3 about here] 
[figure 3 about here] 
 
Discussion 
This is the first study to explore the efficacy of ESFA therapy for people with aphasia 
utilizing a quasi-randomised controlled trial design, rather than a case-study or case-
series approach.  We found a significant difference on the primary outcome measure 
(naming) between the two groups, with the control group showing a small improvement 
across time, in contrast to the therapy group that improved substantially from pre to post 
therapy. Unlike the control group, the therapy group also showed improvements in 
psychosocial and overall quality of life after therapy, but these differences were not 
significant after adjusting for multiple comparisons. 
These findings are important as they provide evidence for the efficacy of ESFA. 
Changes in naming for the therapy group went over and beyond changes in the control 
group, which could be attributed to the regular contact and language-related activities that 
participants had during this time with neurolinguistics and neuropsychology researchers 
in the broader Thales-Aphasia project; or to familiarity with the assessment task (Dorry 
& Hough, 2010). Despite the focus of therapy on creating phrases with the words 
retrieved, there were no significant differences in partner-rated functional communication 
and discourse. This outcome could be due to ESFA, as an impairment – based therapy not 
targeting communication, but only naming improvement. Though participants went 
beyond the single word level to producing phrases and sentences, their utterances did not 
have communicative intent.  Promoting the use of single words acquired in therapy in 
genuine communication activities and specifically training on discourse tasks may be 
required to lead to positive changes in individuals’ discourse and functional 
communication (Peach & Reuter, 2010; Antonucci, 2009; Falconer & Antonucci, 2012). 
With regards to the changes in psychosocial and overall quality of life, the 
moderate to large effect sizes suggest that there is a pattern in the data that should be 
investigated further in future research.  The differences observed in this study for the 
therapy group (mean difference 0.40-0.55 for psychosocial, 0.21-0.28 for overall score) 
exceed what has been identified as the minimal clinically important difference on the 
SAQOL-39g for people with aphasia (0.21) (Guo et al., 2016).  This study is among the 
first randomized controlled studies exploring the impact of a speech and language 
intervention on quality of life. Strong evidence in this area comes from a German 
randomized controlled trial of 158 participants with aphasia, which reported gains on the 
SAQOL-39 following intensive speech and language therapy (Breitenstein et al., 2016). 
There are differences between this study and ours. The German study tested an intensive 
intervention (≥10 h per week), delivered over three weeks; and the intervention 
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comprised both linguistic-cognitive and communicative-pragmatic approaches. As this 
body of literature emerges, it will help us understand better what intervention 
components are important in aphasia therapies to lead to quality of life gains. 
This study also compared ESFA therapy delivered in two different approaches- 
individual and combination. Findings suggested that both individual and combination 
participants showed therapy gains on naming, they maintained these gains and showed a 
generalisation effect on naming untreated words (BNT). Significant others perceived a 
significant change in the communication skills of their partners with aphasia and there 
was change in quality of life post therapy though this difference did not remain 
significant after adjusting for multiple comparisons.  
We anticipated differences in outcomes between the two approaches. We 
anticipated that combination therapy participants would make greater gains in 
communication since they had group therapy, and individual therapy participants in 
naming, since individual therapy is more intensive than group therapy, where practice 
time is divided among the group members (Berthier & Pulvermüller, 2011). There were 
no significant differences in the pattern of change across time between the two groups.   
In terms of communication, this may be due to the nature of the treatment offered, which 
was the same in both the individual and the combination approaches. Participants in both 
approaches received a highly structured therapy, rather than the group sessions following 
a conversation-based approach, as is common in aphasia group therapy (Elman, 2007). 
This meant that participants did not have the opportunity to use their skills in real life 
conversations, which could have led to greater gains in communication outcomes. 
Nevertheless, our findings are in line with the literature. In the recent systematic review 
of aphasia therapies, in those studies that compared individual to group therapy, there 
was no difference in functional communication (Brady et al., 2016).  In terms of naming, 
the similar outcomes in our study between the two approaches may be due to our 
combination participants receiving two individual therapy sessions and one group therapy 
session per week, i.e. two thirds of their therapy sessions or half their total amount of 
therapy was individual. Indeed, recent evidence suggests that a combination of individual 
and group therapy is more efficacious than group therapy alone (Woldag, Voigt, Bley & 
Hummelsheim, 2016).  Still, with both naming and communication outcomes we are 
cautious with our interpretations as our study lacked power to detect significant 
differences between the approaches. 
A positive finding was that naming gains generalized to untrained items for both 
approaches, which compares favourably to studies evaluating SFA in a group context 
(Antonucci, 2009; Falconer & Antonucci, 2012). It also supports Boyle’s (2004) 
suggestion that generalisation in SFA occurs from the repeated methodical accessing of 
the semantic system, regardless of semantic category, as the BNT does not comprise 
items specifically within the semantic categories treated in our study. A further positive 
finding was that gains in naming were maintained at 3-month follow up.  This is an 
important finding that adds to current knowledge on maintenance of gains after SFA.  In 
a recent systematic review of SFA studies (Efstratiadou et al., 2018), maintenance was 
reported for 58.18% of participants, but most of the included studies assessed 
maintenance in the short term, with only 2/21 studies assessing maintenance at 3 months 
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or longer post therapy and only 1/4 participants in these two studies showing a positive 
effect (Davis & Stanton, 2005; Kristensson, Behrns & Saldert, 2015). Lastly, significant 
others perceived an improvement on participants’ functional communicational skills at 
the follow-up assessment. It may be that participants need time to integrate newly 
acquired skills in their communication in everyday life (Kristensson, Behrns & Saldert, 
2015).  Or it may be that it takes time for significant others to notice changes in 
participants’ everyday communication. 
Our results need to be interpreted with caution due to the limitations of the study.  
Main limitations comprise: we did not manage to recruit to target; the randomization 
method was flawed, as participants were randomized before eligibility for speech and 
language therapy was checked; and the overall study tested two different therapies 
(mapping therapy and ESFA), with 36 participants meeting the criteria for ESFA therapy.  
This resulted in an uneven number of participants in the comparison groups and an 
underpowered study. Though small deviations from equality of the sample sizes are not 
detrimental (Schulz & Grimes, 2002), results of underpowered studies have to be 
interpreted carefully. It is uncertain whether the lack of statistical significance in the 
comparisons made is a true finding or a false negative. This limitation is acknowledged. 
Still, in our study, effect sizes were large for the main outcome measure and moderate – 
large for the significant secondary outcome measures. Lastly, in underpowered or not 
well-randomized and controlled studies, differences in outcomes could be due to 
differences in characteristics or other variables between participant groups. In our study, 
despite these limitations, no differences were found in demographics and aphasia related 
variables between the groups.   
Strengths of the study include its controlled design, recruitment from a range of 
settings, and the broad eligibility criteria.  Recruiting from a variety of geographic 
settings and from both state and private hospitals / rehabilitation centres ensured social 
and economic biases in participant selection were minimized.  As a result, the 
demographic characteristics of the study sample were similar to the Greek stroke 
population (Vasiliadis & Zikić, 2014). In terms of eligibility criteria, in order to detect the 
effects of treatment in specific conditions, RCTs typically have inclusion and exclusion 
criteria that are quite restrictive. There is evidence that RCT populations usually don't 
mirror the age, gender, and race distribution of the target patient population (McKee et 
al., 1999; Sørensen, Lash & Rothman, 2006). In this study inclusion and exclusion 
criteria were broad and therefore our sample comprised people with a range of aphasia 
types, severities and times post-onset.  The inclusion of people with severe aphasia 
should be noted. Unlike the current study, the majority of participants (33/55) in a recent 
systematic review of SFA studies were fluent and had mostly mild aphasias (Conduction 
and Anomic), and only 5/55 participants had severe aphasia (Efstratiadou et al., 2018).  In 
contrast, in our study 19/38 (50%) of participants had severe aphasia.  Our study, 
therefore, extends the evidence base of SFA therapy for aphasia to those with severe 
aphasia. 
Another strength of the study is the use of a range of outcome measures tapping 
on all levels of the World Health Organisation International Classification of Functioning 
(WHO ICF) framework (WHO, 2001) and quality of life. This ensured key aspects of 
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health were considered. The goals of people with aphasia span the full spectrum of the 
ICF, with primary goals typically linked to the activity / participation and the body 
functions and structures levels (Worrall et al., 2011; Wallace et al., 2016). We also 
included the SAQOL-39g as a measure of quality of life, which has since been identified 
as a key measure of the Core Outcome Set for Aphasia (Wallace et al., 2018).  Core 
Outcome Sets promote the use of a minimum set of outcomes in intervention studies to 
allow for data to be collated across studies and for comparisons between studies. 
In summary, ESFA therapy led to greater improvements in naming for those in 
the intervention versus those in the control group. Trends were also observed for 
improvements in psychosocial and overall quality of life. When comparing their relative 
efficacy, both individual and combination ESFA led to improvements in naming, with 
generalization to untreated items and these gains were maintained at 3-month follow-up. 
Significant others perceived benefits in the communication skills of their partners with 
aphasia at the 3-month follow-up.  Admittedly, due to the flaws in our randomization 
process and the smaller than intended sample size, this study has not provided level I 
definitive evidence on the efficacy of ESFA; it has, however, provided level II evidence. 
This is of significance, considering that current best practice statements for aphasia 
therapy for word retrieval deficits (Clinical Centre for Research Excellence in Aphasia 
Rehabilitation, 2014) are based on level III/IV evidence (Wisenburn & Mahoney, 2009). 
Additionally, the recent Cochrane review of aphasia therapy studies did not find evidence 
from trials of speech and language therapy vs. no speech and language therapy to support 
naming therapy (Brady et al., 2016).  Further research is needed to confirm the reliability 
of the results in well-powered studies. Such studies could also allow for subgroup 
analysis in terms of aphasia type and severity and further inform candidacy for ESFA. 
 
Conclusion/ clinical messages 
 
Elaborated semantic features analysis (ESFA) can improve naming in people with 
different types and severities of aphasia, including those with severe aphasia.  Both those 
who had ESFA in individual therapy and those who had a combination of individual and 
group therapy sessions made gains in naming and functional communication. 
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Figure 1: CONSORT diagram of participant flow in the study  
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Table 1: Participant characteristics of therapy group (n=26) and control/ delayed 
therapy group (n=12) 
 
Variables Therapy Group (n=26) Control / Delayed Therapy 
Group (n= 12) 
Age (years) 
Mean (SD) 
Range 
 
58.38 (11.26) 
38 – 84 
 
58.42 (11.99) 
44 - 79 
Gender 
Male 
Female 
 
20 
6 
 
6 
6 
Time Post Onset (months) 
Mean (SD) 
Range 
 
36.73 (49.30) 
4 - 207 
 
16.00 (21.89) 
4 - 78 
Work Status 
Full – time 
Part – time 
Self-employed 
Unemployed 
Retired due to age 
Retired due to disability 
 
11 
1 
4 
- 
8 
2 
 
6 
1 
1 
1 
3 
- 
Marital Status 
Single 
Married 
Divorced 
Widowed 
 
2 
17 
5 
2 
 
2 
6 
2 
2 
Education Status (years) 
Mean (SD) 
Range 
 
13.27 (3.80) 
6 - 20 
 
13.00 (4.45) 
6 - 21 
Type of Stroke 
Haemorrhagic 
Ischaemic 
 
- 
26 
 
1 
11 
Aphasia Type (based on BDAE) 
Broca’s 
Wernicke’s 
Anomic 
Global 
Conduction 
Unclassified 
 
9 
1 
5 
7 
- 
4 
 
5 
- 
1 
3 
2 
1 
Aphasia Severity (BDAE) 
Mild 
Moderate 
Severe 
 
5 
7 
14 
 
3 
4 
5 
Fluency Status (BDAE) 
Fluent 
Non Fluent 
 
5 
21 
 
5 
7 
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Table 2: Therapy (n=26) and control group (n=12) scores on outcome measures across time 
 Mean (SD) scores Time effect Interaction effect 
Measure Group BL1 BL2 Post therapy/BL3 p η2p 
(90% CIs) 
p η2p 
(90% CIs) 
S & V Control 
Therapy 
67.83 (57.29) 
56.15 (45.74) 
74.33 (62.94) 
61.96 (49.50) 
81.83 (69.90) 
104.38 (73.91) 
<.001 .42 
(.22 - .56) 
.003 .21 
(.05 - .37) 
BNT Control 
Therapy 
7.75 (5.45) 
6.85 (7.17) 
8.92 (6.87) 
6.81 (6.53) 
10 (8.37) 
9.84 (9.29) 
.002 0.19 
(.05 - .33) 
ns .04 
(.00 - .14) 
ASHA-FACS Control 
Therapy  
4.91 (1.19) 
5.24 (1.09) 
5.13 (1.13) 
5.24 (1.13) 
5.28 (1.09) 
5.55 (.92) 
ns 0.12 
(.01 - .25) 
ns .01 
(.00 - .08) 
Discourse Control 
Therapy 
17.65 (24.47) 
16.35 (24.62) 
19.16 (23.81) 
15.22 (23.11) 
18.64 (22.47) 
18.14 (30.04) 
ns .01 
(.00 -.08) 
ns .02 
(.00 - .10) 
GHQ-12 Control 
Therapy 
6.00 (2.41) 
6.27 (1.93) 
5.50 (2.39) 
6.04 (2.44) 
6.17 (2.17) 
6.12 (1.66) 
ns .01 
(.00 - .07) 
ns .01 
(.00 - .05) 
SAQOL-39g 
Physical  
 
 
Psychosocial 
 
 
Communication 
 
 
Overall 
 
 
Control 
Therapy 
 
Control 
Therapy 
 
Control 
Therapy 
 
Control 
Therapy 
 
 
3.31 (1.02) 
3.80 (1.01) 
 
2.75 (.78) 
3.07 (1.04) 
 
2.52 (.78) 
2.77 (.90) 
 
2.94 (.60) 
3.31 (.75) 
 
3.20 (1.12) 
3.79 (.98) 
 
2.95 (.77) 
2.92 (.98) 
 
2.83 (1.07) 
2.82 (.90) 
 
3.01 (.69) 
3.24 (.73) 
 
3.17 (.95) 
3.89 (.92) 
 
2.63 (.82) 
3.47(.93) 
 
2.65 (1.18) 
2.86 (.91) 
 
2.83 (.54) 
3.52 (.72) 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
.01 
(.00 - .05) 
 
.01 
(.00 - .08) 
 
.04 
(.00 - .14) 
 
.01 
(.00 - .05) 
 
 
ns 
 
 
p= .013 
 
 
ns 
 
 
p= .015 
 
.03 
(.00 - .10) 
 
.12 
(.02 - .24) 
 
.03 
(.00 - .11) 
 
.11 
(.01 - .22) 
EQ-5D 
 
Control 
Therapy 
60.83 (23.53) 
63.54 (19.35) 
55.42 (20.61) 
67.12 (16.62) 
50.83(15.20) 
69.12(15.59) 
ns .01 
(.00 - .04) 
ns .08 
(.00 - .18) 
ASHA-FACS: American Speech and Hearing Association Functional Assessment of Communication Skills; BL: baseline; BNT: 
Boston Naming Test; CIs: Confidence Intervals; GHQ-12: General Health Questionnaire – 12 item version; ns: not significant; 
SAQOL-39g: Stoke and Aphasia Quality of Life Scale- 39 item generic stroke version; SD: Standard Deviation; S &V: Snodgrass and 
Vanderwart naming measure. 
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Table 3: Individual therapy (n=22) and combination therapy (n=14) group scores on outcome measures across time 
 Mean (SD) scores Time effect Interaction effect 
Measure Therapy 
group 
BL1 BL2 Post 
therapy 
Follow up p η2p 
(90% CIs) 
p η2p 
(90% CIs) 
S & V Individual 
Combination 
58.91 (50.14) 
62.14 (49.67) 
66.23 (53.95) 
75.29 (62.64) 
103.64 (77.01) 
116.79 (79.45) 
96.32 (68.49) 
111.64 (76.90) 
p< .001 .49 
(.33 - .59) 
ns .01 
(.00 - .06) 
BNT Individual 
Combination 
6.95 (6.74) 
7.50 (6.98) 
7.41 (7.22) 
8.00 (6.21) 
10.77 (10.80) 
13.14 (10.28) 
10.32 (10.27) 
11.21 (10.14) 
p< .001 .29 
(.13 - .41) 
ns .01 
(.00 - .07) 
ASHA-FACS Individual 
Combination 
5.21 (1.12) 
5.11 (1.13) 
5.30 (1.08) 
5.15 (1.20) 
5.55 (.94) 
5.44 (.97) 
6.02 (.73) 
5.47 (1.18) 
p= .001 .18 
(.05 - .29) 
ns .03 
(.00 - .10) 
Discourse Individual 
Combination 
16.18 (25.03) 
17.45 (21.87) 
14.74 (24.73) 
16.63 (18.15) 
17.43 (31.03) 
18.23 (21.48) 
17.93 (27.80) 
17.13 (21.71) 
ns .03 
(.00 - .08) 
ns .01 
(.00 - .04) 
GHQ-12 Individual 
Combination 
6.32 (1.91) 
5.50 (1.99) 
5.91 (2.39) 
5.50 (2.50) 
6.00 (1.72) 
5.21 (2.19) 
5.86 (1.67) 
6.00 (1.75) 
ns .01 
(.00 - .04) 
ns .02 
(.00 - .06) 
SAQOL-39g 
Physical  
 
 
Psychosocial 
 
 
Communication 
 
 
Overall 
 
Individual 
Combination 
 
Individual 
Combination 
 
Individual 
Combination 
 
Individual 
Combination 
 
3.62 (1.05) 
3.91 (.87) 
 
2.87 (1.02) 
3.18 (.94) 
 
2.60 (.90) 
2.92 (.79) 
 
3.13 (.75) 
3.43 (.60) 
 
3.64 (1.07) 
3.74 (.98) 
 
2.91 (1.05) 
3.01 (.73) 
 
2.68 (.98) 
3.03 (.76) 
 
3.15 (.79) 
3.28 (.61) 
 
3.82 (.91) 
3.98 (.85) 
 
3.08 (1.10) 
3.53 (.70) 
 
2.71 (.97) 
3.12 (.94) 
 
3.31 (.78) 
3.62 (.57) 
 
3.66 (1.07) 
3.86 (1.06) 
 
3.32 (.92) 
3.26 (.83) 
 
2.78 (.95) 
3.26 (1.15) 
 
3.35 (.78) 
3.49 (.73) 
 
ns 
 
 
ns 
 
 
ns 
 
 
p= .046 
 
 
.05 
(.00 - .12) 
 
.07 
(.00 - .15) 
 
.05 
(.00 - .13) 
 
.09 
(.001 - .18) 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
.01 
(.00 - .04) 
 
.03 
(.00 - .09) 
 
.01 
(.00 - .03) 
 
.02 
(.00 - .07) 
EQ-5D Individual 
Combination 
63.73 (18.37) 
59.29 (25.26) 
63.41 (18.86) 
63.57 (19.46) 
67.14 (17.06) 
68.21 (17.05) 
66.82 (13.23) 
70.71 (14.53) 
ns .07 
(.00 - .14) 
ns .02 
(.00 - .06) 
ASHA-FACS: American Speech and Hearing Association Functional Assessment of Communication Skills; BL: baseline; BNT: 
Boston Naming Test; GHQ-12: General Health Questionnaire – 12 item version; ns: not significant; SAQOL-39g: Stoke and Aphasia 
Quality of Life Scale- 39 item generic stroke version; S &V: Snodgrass and Vanderwart naming measure. 
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Figure 2: Interaction effects for therapy (n=26) versus control group (n=12) across 
time for S&V, BNT, ASHA-FACS, Discourse, GHQ-12, EQ-5D, and SAQOL-39 
overall and psychosocial 
 
 
ASHA-FACS: American Speech and Hearing Association Functional Assessment of Communication 
Skills; BL: baseline; BNT: Boston Naming Test; GHQ-12: General Health Questionnaire – 12 item 
version; ns: not significant; SAQOL-39g: Stoke and Aphasia Quality of Life Scale- 39 item generic stroke 
version; S &V: Snodgrass and Vanderwart naming measure. 
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Figure 3: Interaction effects for individual therapy (n=22) versus combination 
therapy (n=14) across time for S&V, BNT, ASHA-FACS, Discourse, GHQ-12, EQ-
5D, and SAQOL-39 overall. 
 
 
 
ASHA-FACS: American Speech and Hearing Association Functional Assessment of Communication 
Skills; BL: baseline; BNT: Boston Naming Test; GHQ-12: General Health Questionnaire – 12 item 
version; ns: not significant; SAQOL-39g: Stoke and Aphasia Quality of Life Scale- 39 item generic stroke 
version; S &V: Snodgrass and Vanderwart naming measure. 
